← Back to Search

Local Anesthetic

Lidocaine Infusion for Chronic Pain in Children

Phase 3
Waitlist Available
Led By Lisa Isaac, MD
Research Sponsored by The Hospital for Sick Children
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week prior to the infusion and at two and four weeks following the infusion.
Awards & highlights

Study Summary

This trial will test if lidocaine can help relieve chronic pain in children and if it is safe to use.

Eligible Conditions
  • Chronic Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~intraoperative
This trial's timeline: 3 weeks for screening, Varies for treatment, and intraoperative for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain Score
Secondary outcome measures
Adverse Events
Analgesic Requirement
Other outcome measures
Pain Interference
School Attendance
Sleep

Side effects data

From 2014 Phase 4 trial • 40 Patients • NCT01602692
40%
Nausea
10%
Vomiting
100%
80%
60%
40%
20%
0%
Study treatment Arm
Tumescent Solution With Dilute Epinephrine
Tumescent Solution With Dilute Lidocaine and Epinephrine

Trial Design

1Treatment groups
Experimental Treatment
Group I: Lidocaine InfusionExperimental Treatment1 Intervention
All participants will receive intravenous lidocaine infusion of 42 mcg/kg/minute over 2 hours, for a total of 5 mg/kg. No bolus dose will be given.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lidocaine Infusion
2010
Completed Phase 4
~410

Find a Location

Who is running the clinical trial?

The Hospital for Sick ChildrenLead Sponsor
689 Previous Clinical Trials
6,945,402 Total Patients Enrolled
8 Trials studying Chronic Pain
1,028 Patients Enrolled for Chronic Pain
Lisa Isaac, MDPrincipal InvestigatorThe Hospital for Sick Children

Media Library

Lidocaine (Local Anesthetic) Clinical Trial Eligibility Overview. Trial Name: NCT02983682 — Phase 3
Chronic Pain Research Study Groups: Lidocaine Infusion
Chronic Pain Clinical Trial 2023: Lidocaine Highlights & Side Effects. Trial Name: NCT02983682 — Phase 3
Lidocaine (Local Anesthetic) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02983682 — Phase 3

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To be eligible for this test, what do potential participants need to qualify?

"This clinical trial is looking for 20 participants, aged 8-18, who have chronic pain that has not responded to other treatments. Eligible patients must also meet the following criteria: American Society of Anesthesiologists class 1 or 2, ability to understand and use the numeric rating scale to rate their pain, and negative pregnancy test for participants of child-bearing potential (females 12 years of age and older, or menarchal if under 12)."

Answered by AI

Has the FDA cleared Lidocaine Infusion for public use?

"Lidocaine Infusion received a score of 3 on Power's safety scale. This is due to Phase 3 trial data, which provides support for both efficacy and safety."

Answered by AI

Are there any other similar case studies to the Lidocaine Infusion?

"There are a total of 135 clinical trials studying lidocaine infusion, 34 of which are in Phase 3. Although most research is conducted in Calgary, Alberta, lidocaine infusion studies are being conducted at 1,110 locations worldwide."

Answered by AI

Are adults the only age group being recruited for this trial?

"According to the eligibility criteria for this trial, the minimum age for enrollment is 8 and the maximum age is 18."

Answered by AI

What are some of the conditions that Lidocaine Infusion is known to help?

"Lidocaine Infusion is commonly used to alleviate cervical syndrome, but it can also be used to help patients with minor burns, osteoporosis, and transplantation."

Answered by AI
~2 spots leftby Apr 2025